These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 2373872)
1. Prophylactic and therapeutic effects of a monoclonal antibody to tumor necrosis factor-alpha in experimental gram-negative shock. Silva AT; Bayston KF; Cohen J J Infect Dis; 1990 Aug; 162(2):421-7. PubMed ID: 2373872 [TBL] [Abstract][Full Text] [Related]
2. Role of interferon-gamma in experimental gram-negative sepsis. Silva AT; Cohen J J Infect Dis; 1992 Aug; 166(2):331-5. PubMed ID: 1634804 [TBL] [Abstract][Full Text] [Related]
3. Monoclonal antibody to endotoxin core protects mice from Escherichia coli sepsis by a mechanism independent of tumor necrosis factor and interleukin-6. Silva AT; Appelmelk BJ; Buurman WA; Bayston KF; Cohen J J Infect Dis; 1990 Aug; 162(2):454-9. PubMed ID: 2197338 [TBL] [Abstract][Full Text] [Related]
4. Observations on the role of tumor necrosis factor-alpha in a murine model of shock due to Streptococcus pyogenes. Wayte J; Silva AT; Krausz T; Cohen J Crit Care Med; 1993 Aug; 21(8):1207-12. PubMed ID: 8339588 [TBL] [Abstract][Full Text] [Related]
5. Anti-lipopolysaccharide and anti-tumor necrosis factor/cachectin antibodies for the treatment of gram-negative bacteremia and septic shock. Calandra T; Baumgartner JD; Glauser MP Prog Clin Biol Res; 1991; 367():141-59. PubMed ID: 1924424 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of antilipopolysaccharide and anti-tumor necrosis factor monoclonal antibodies in a neutropenic rat model of Pseudomonas sepsis. Opal SM; Cross AS; Sadoff JC; Collins HH; Kelly NM; Victor GH; Palardy JE; Bodmer MW J Clin Invest; 1991 Sep; 88(3):885-90. PubMed ID: 1885775 [TBL] [Abstract][Full Text] [Related]
9. Differential effect of isotype on efficacy of anti-tumor necrosis factor alpha chimeric antibodies in experimental septic shock. Suitters AJ; Foulkes R; Opal SM; Palardy JE; Emtage JS; Rolfe M; Stephens S; Morgan A; Holt AR; Chaplin LC J Exp Med; 1994 Mar; 179(3):849-56. PubMed ID: 8113678 [TBL] [Abstract][Full Text] [Related]
10. Effect of anti-TNF-alpha treatment in an antibiotic treated murine model of shock due to Streptococcus pyogenes. Martin RA; Silva AT; Cohen J FEMS Microbiol Lett; 1993 Jun; 110(2):175-8. PubMed ID: 8349091 [TBL] [Abstract][Full Text] [Related]
18. Evidence for tumor necrosis factor alpha as a mediator of the toxicity of a cyclooxygenase inhibitor in Gram-negative sepsis. Campanile F; Giampietri A; Grohmann U; Belladonna ML; Fioretti MC; Puccetti P Eur J Pharmacol; 1996 Jun; 307(2):191-9. PubMed ID: 8832221 [TBL] [Abstract][Full Text] [Related]
19. Survival of primates in LD100 septic shock following therapy with antibody to tumor necrosis factor (TNF alpha). Hinshaw LB; Tekamp-Olson P; Chang AC; Lee PA; Taylor FB; Murray CK; Peer GT; Emerson TE; Passey RB; Kuo GC Circ Shock; 1990 Mar; 30(3):279-92. PubMed ID: 2178801 [TBL] [Abstract][Full Text] [Related]
20. Antibody immunotherapy of gram-negative bacterial sepsis in an immunosuppressed animal model. Dunn DL Transplantation; 1988 Feb; 45(2):424-9. PubMed ID: 3278438 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]